Julien Péron

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Solène De Talhouet, Julien Péron, Aurélie Vuilleumier et al. · Scientific Reports · 2020 · 129 citations · Full text

Life Sciences, Genetics, Oncology +15

Inclusion of elderly patients in oncology clinical trials

Olivia Le Saux, Claire Falandry, Hui Gan et al. · Annals of Oncology · 2016 · 114 citations · Full text

Medicine, Geriatric Medicine, Oncology +13

Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting

Pauline Corbaux, Denis Maillet, Amélie Boespflug et al. · European Journal of Cancer · 2019 · 83 citations · Full text

Life Sciences, Immunology, Oncology +14

Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors

Denis Maillet, Pauline Corbaux, Jean‐Jacques Stelmes et al. · European Journal of Cancer · 2020 · 76 citations

Life Sciences, Immunology, Oncology +16

Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy

Olivier Bylicki, Hui Gan, Florence Joly et al. · Annals of Oncology · 2014 · 75 citations · Full text

Pharmacy, Oncology, Outcomes Research +14